Komori
Governance4523Eisai Co.,Ltd.Pharmaceuticals

Notice Regarding the Continuation of the Share-Based Compensation Plan (BIP Trust for Directors’ Compensation)

The share-based compensation plan and BIP Trust for directors and executive officers will continue, and the trust period will be extended by 3 years through the end of July 2029. In connection with this, an additional ¥1,584.42 million will be placed in the trust, which is expected to acquire 345,600 treasury shares.

Worth reading
16Immaterial
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
158442
¥10,000
Wording
Conditional
How definitive the wording is.

Governance structure

Company with Three Statutory Committees
Committee1
Compensation committee
Changes this time

The share-based compensation plan and the trust will continue, and the trust period is expected to be extended through the end of July 2029. An additional ¥1,584.42 million is expected to be placed in the trust, and an additional 345,600 shares are expected to be acquired.

Governance structure
ItemDetails
Corporate Governance StructureCompany with Three Statutory Committees
CommitteeCompensation committee (percentage of outside members: not disclosed)
Changes this timeThe share-based compensation plan and the trust will continue, and the trust period is expected to be extended through the end of July 2029. An additional ¥1,584.42 million is expected to be placed in the trust, and an additional 345,600 shares are expected to be acquired.
Items this document does not state (5)
Number of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To strongly motivate directors to oversee management and executive officers to perform their duties, and to enhance their motivation to increase corporate value over the medium to long term. The additional trust amount was calculated by adding trust fees and expenses to the current compensation amounts for directors and executive officers. The number of additional shares to be acquired was set with reference to the current share price and the composition of the officers, at the level required if the Company achieves its overall performance targets at the maximum level.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Continuation of the Share-Based Compensation Plan (BIP Trust for Directors’ Compensation) | Eisai Co.,Ltd. (4523) timely disclosure | Komori